Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2008-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung Cancer
NCT02941003
EB-OCT Biopsy Guidance of Lung Cancer
NCT06556680
Development of Innovative Preclinical Ex Vivo Models for the Study of Sarcomas and Metastases From Solid Tumors
NCT07112989
Real-Time Optical Biopsy in Improving Lung Cancer Diagnosis in Patients Undergoing Lung Biopsy
NCT03376971
Integrative Analysis of Large-cell Lung Cancer
NCT02917369
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Creating a database of tissue lesions and their 'optical signature' (lesion classifier).
Optimization of the FOSTI device by minimizing the false-positive and false-negative results.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is able, agree and sign the Informed Consent Form.
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Optivasive Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Optivasive Ltd.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anatoliy Babchenko
Role: STUDY_DIRECTOR
Optivasive Ltd.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OpVe-HI-08-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.